AHA Scientific Sessions 2025 Abstract

Healthcare Resource Utilization and Costs Before and After Evolocumab Initiation Among Patients With Atherosclerotic Cardiovascular Disease: A Real-World Administrative Claims Analysis

Study in peopleInterventions

The paper

Amgen (United States); Complete HEOR Solutions

AHA Scientific Sessions 2025 Abstract, 3 Nov 2025

Presented at AHA Scientific Sessions 2025, abstract 4365637

doi.org/10.1161/circ.152.suppl_3.4365637